Back
PTC Therapeutics Vs. Blueprint Medicines Industry Stock Comparison
Sell
34
PTCT
PTC Therapeutics
Last Price:
$46.22
Seasonality Move:
7.01%
Sell
40
BPMC
Blueprint Medicines
Last Price:
$90.24
Seasonality Move:
2.18%
Sell
34
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
-
The current PTC Therapeutics [PTCT] share price is $46.24. The Score for PTCT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $46.24The current trend is moderately bearish and PTCT is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $90.19Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.94 | Buy |
Relative Strength Index (14 RSI): | 51.29 | Buy |
Chaikin Money Flow: | 155621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.36 - 49.38) | Buy |
Bollinger Bands (100): | (33.33 - 44.39) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 42.23 | Sell |
Chaikin Money Flow: | 540770 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.73 - 96.57) | Sell |
Bollinger Bands (100): | (87.46 - 96.54) | Sell |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.01 | Sell |
20-day SMA: | 47.2 | Sell |
50-day SMA: | 43.41 | Buy |
200-day SMA: | 35.45 | Buy |
8-day EMA: | 46.71 | Sell |
20-day EMA: | 46.41 | Sell |
50-day EMA: | 43.72 | Buy |
200-day EMA: | 37.27 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.88 | Sell |
20-day SMA: | 94.44 | Sell |
50-day SMA: | 92.37 | Sell |
200-day SMA: | 96.72 | Sell |
8-day EMA: | 92.45 | Sell |
20-day EMA: | 93.6 | Sell |
50-day EMA: | 93.36 | Sell |
200-day EMA: | 91.74 | Sell |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $0.14 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.
PTC Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |